ES2080955T3 - Anticuerpos especificos de la pancreaelastasa 1, procedimiento para su obtencion y equipo de analisis que contiene este tipo de anticuerpos. - Google Patents

Anticuerpos especificos de la pancreaelastasa 1, procedimiento para su obtencion y equipo de analisis que contiene este tipo de anticuerpos.

Info

Publication number
ES2080955T3
ES2080955T3 ES91912932T ES91912932T ES2080955T3 ES 2080955 T3 ES2080955 T3 ES 2080955T3 ES 91912932 T ES91912932 T ES 91912932T ES 91912932 T ES91912932 T ES 91912932T ES 2080955 T3 ES2080955 T3 ES 2080955T3
Authority
ES
Spain
Prior art keywords
antibodies
obtaining
pancreaelastase
procedure
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91912932T
Other languages
English (en)
Inventor
Hans Scheefers
Ursula Scheefers-Borchel
Andreas Sziegoleit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SCHEBO TECH MEDIZINISCH BIOLOG
ScheBo Tech Medizinisch-Biologische Forschungsgesellschaft mbH
Original Assignee
SCHEBO TECH MEDIZINISCH BIOLOG
ScheBo Tech Medizinisch-Biologische Forschungsgesellschaft mbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SCHEBO TECH MEDIZINISCH BIOLOG, ScheBo Tech Medizinisch-Biologische Forschungsgesellschaft mbH filed Critical SCHEBO TECH MEDIZINISCH BIOLOG
Application granted granted Critical
Publication of ES2080955T3 publication Critical patent/ES2080955T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6448—Elastases, e.g. pancreatic elastase (3.4.21.36); leukocyte elastase (3.4.31.37)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

SE DESCRIBE UN PROCEDIMIENTO PARA LA OBTENCION DE ANTICUERPOS DE ELASTASA 1 DEL PANCREAS, ALTAMENTE ESPECIFICOS, QUE REACCIONAN TANTO CON LOS FLUIDOS CORPORALES COMO TAMBIEN CON LAS HECES. UN ANTICUERPO TAL ES OBTENIBLE POR MEDIO DE LA INMUNIZACION CON UN ANTIGENO, QUE POSEA LA SECUENCIA DE AMINOACIDOS THR-MET-VAL-ALAGLY-GLY-ASP-ILE-ARG, O PEPTIDOS PARCIALES DE ELLOS, ACTIVOS INMUNOLOGICAMENTE. UNA UNIDAD DE ENSAYO QUE CONTENGA DICHOS ANTICUERPOS ES ADECUADO PARA EL DIAGNOSTICO Y PARA EL CONTROL DE SEGUIMIENTO DE PANCREATITIS CRONICAS Y AGUDAS, ASI COMO DE MUCOVISCIDOSIS EN LOS FLUIDOS CORPORALES Y/O EN LAS HECES.
ES91912932T 1990-07-28 1991-07-28 Anticuerpos especificos de la pancreaelastasa 1, procedimiento para su obtencion y equipo de analisis que contiene este tipo de anticuerpos. Expired - Lifetime ES2080955T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4023972 1990-07-28
DE4107765A DE4107765A1 (de) 1990-07-28 1991-03-11 Pankreas-elastase-1-spezifischer antikoerper, ein verfahren zu seiner gewinnung und ein testkit der solche antikoerper enthaelt

Publications (1)

Publication Number Publication Date
ES2080955T3 true ES2080955T3 (es) 1996-02-16

Family

ID=25895430

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91912932T Expired - Lifetime ES2080955T3 (es) 1990-07-28 1991-07-28 Anticuerpos especificos de la pancreaelastasa 1, procedimiento para su obtencion y equipo de analisis que contiene este tipo de anticuerpos.

Country Status (10)

Country Link
EP (1) EP0547059B1 (es)
JP (2) JPH05508770A (es)
AT (1) ATE128734T1 (es)
AU (1) AU646476B2 (es)
CA (1) CA2088354C (es)
DE (2) DE4107765A1 (es)
DK (1) DK0547059T3 (es)
ES (1) ES2080955T3 (es)
GR (1) GR3018483T3 (es)
WO (1) WO1992002630A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0488470B1 (en) * 1990-11-26 1997-05-28 Akzo Nobel N.V. Method for the production of antibodies
EP0958833A1 (en) * 1998-05-20 1999-11-24 Erasmus Universiteit Rotterdam Methods and means for preventing or treating inflammation
DE59913651D1 (de) * 1998-09-08 2006-08-17 Bioserv Analytik Und Medizinpr Diagnostisches verfahren zur erkennung einer pankreasfunktionsstörung
DE19923892A1 (de) 1998-09-08 2000-03-09 Privates Inst Bioserv Gmbh Diagnostisches Verfahren zur Erkennung einer Pankreasfunktionsstörung
GB9908458D0 (en) * 1999-04-13 1999-06-09 Queen Mary & Westfield College Enzyme
DE10157336B4 (de) * 2000-11-24 2007-07-19 Bioserv Analytik Und Medizinprodukte Gmbh Verfahren zur Herstellung eines Testsystems und Diagnoseverfahren zur Erkennung von Pankreasfunktionsstörungen
DE10101792B4 (de) * 2001-01-17 2004-03-18 Vivotec Biomedical Technologies Gmbh Verfahren zum Nachweis von Pankreaskarzinom oder chronischer Pankreatitis und Verwendung von Antikörpern
JP2006226795A (ja) * 2005-02-16 2006-08-31 Tokyo Univ Of Science 急性膵炎の診断マーカー
CN111044723A (zh) 2018-10-12 2020-04-21 谢鲍生物科技股份公司 含有胰弹性蛋白酶-1-特异性的抗体以及样品准备装置的新型测试试剂盒
WO2023100910A1 (ja) * 2021-11-30 2023-06-08 株式会社Ｌｓｉメディエンス 糞便中エラスターゼ１を測定する方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5925183B2 (ja) * 1978-07-05 1984-06-15 ダイナボット株式会社 エラスタ−ゼ−１の測定方法
JP2617299B2 (ja) * 1986-09-17 1997-06-04 ダイナボット 株式会社 エラスターゼ１の免疫学的測定方法

Also Published As

Publication number Publication date
CA2088354C (en) 1999-09-28
EP0547059A1 (de) 1993-06-23
CA2088354A1 (en) 1992-01-29
DE4107765A1 (de) 1992-01-30
ATE128734T1 (de) 1995-10-15
JPH05508770A (ja) 1993-12-09
AU8100291A (en) 1992-03-02
EP0547059B1 (de) 1995-10-04
DK0547059T3 (da) 1996-02-19
DE59106634D1 (de) 1995-11-09
WO1992002630A1 (de) 1992-02-20
AU646476B2 (en) 1994-02-24
GR3018483T3 (en) 1996-03-31
JPH1080272A (ja) 1998-03-31

Similar Documents

Publication Publication Date Title
DE3584196D1 (de) Immunologisches testverfahren.
ES2080955T3 (es) Anticuerpos especificos de la pancreaelastasa 1, procedimiento para su obtencion y equipo de analisis que contiene este tipo de anticuerpos.
DE58905081D1 (de) Verfahren zur bestimmung eines proteins nach dem prinzip des fluoreszenz-polarisations immunoassays.
ATE244299T1 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
DK0597847T3 (da) Syntetisk senescentcelleantigen
ATE46703T1 (de) Regionspezifische determinanten fuer vitamin-k abhaengiges knochenprotein.
SE8004542L (sv) Diagnostiskt test
DE69034254D1 (de) A-pdgf-rezeptor und dessen verwendung
EP0582243A3 (de) HCV Peptidantigene und Verfahren zur Bestimmung von HCV.
DE3688204D1 (de) Monoklonaler antikoerper gegen ein p21-bezuegliches dodekapeptid des ras-onkogens.
SE8900899D0 (sv) Peptides for diagnostic use
ATE143673T1 (de) Testverfahren von glykosylierten proteinen unter verwendung eines antikörpers gerichtet gegen reduzierte glykosylierte n-terminal-aminosäuren
Harris et al. Serologic response to streptococcal hemolysin and hyaluronidase in streptococcal and rheumatic infection
JPS55141452A (en) Synthetic polypeptide
DK312088A (da) Hidtil ukendte peptider og anvendelser deraf
Brunson et al. Concanavalin A preparations with activities related to bacterial lipopolysaccharide
JPS55152458A (en) Method of eliminating immunoreaction interference in immunological measurement method
PT81050B (pt) Anticorpo monoclonal anti-urocinase e processo para a preparacao de composicoes de materia de teste biologicos que o utilizam
Bulava et al. Use of immunoenzyme diagnosis of disease caused by Bacillus pyocyaneus.
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
MX170503B (es) , "procedimiento para obtener un reactivo antigenico util para determinar indirectamente salmonella typhi.
Bakulin et al. Method for the preparation of erythrocytic diagnostic reagent for detecting type A Clostridium perfringens enterotoxin.
Belov Correlation between the neutrophil damage index and the passive hemagglutination titers in the detection of antibodies.
Yankina et al. Use of affinity chromatography for obtaining monospecific antibodies.
GR1000377B (el) Νεα πρωτεινη αναγνωρισεως της κυησεως σε θηλαστικα εφαρμογες στην προωρη ανιχνευση της κυησεως και μεθοδος παρασκευης της εν λογω πρωτεινης.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 547059

Country of ref document: ES